Wal-Mart Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts

Manufacturer
Wal-Mart Stores Inc
Effective date
2014-06-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:39:38

Label at a glance#

ProductEquate Naproxen Sodium
Active ingredientNAPROXEN SODIUM
Label structure9 sections

Indications and uses

• temporarily relieves minor aches and pains due to: • minor pain of arthritis • muscular aches • backache • menstrual cramps • headache • toothache • the common cold • temporarily reduces fever

Dosage and administration

• do not take more than directed • the smallest effective dose should be used • drink a full glass of water with each dose • if taken with food, this product may take longer to work adults and children 12 years and older: • take 1 capsule every 8 to 12 hours while symptoms last • for the first dose you may take 2 capsules within the first hour • do not exceed 2 capsules in any 8- to 12-hour period • do not exceed ...

Storage and handling

• each capsule contains: sodium 20 mg • store at 20-25°C (68-77°F) avoid high humidity and excessive heat above 40°C (104°F) • read all directions and warnings before use

Label contents#

Full prescribing information#

Active ingredient (in each capsule)

OTC - ACTIVE INGREDIENT SECTION

Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

Purposes

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves minor aches and pains due to:
  • minor pain of arthritis
  • muscular aches
  • backache
  • menstrual cramps
  • headache
  • toothache
  • the common cold
  • temporarily reduces fever

Warnings

WARNINGS SECTION

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

  • hives
  • facial swelling
  • asthma (wheezing)
  • shock
  • skin reddening
  • rash
  • blisters

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

  • are age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Do not use

OTC - DO NOT USE SECTION

  • if you have ever had an allergic reaction to any other pain reliever/fever reducer
  • right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • the stomach bleeding warning applies to you
  • you have a history of stomach problems, such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, or kidney disease
  • you are taking a diuretic
  • you have problems or serious side effects from taking pain relievers or fever reducers
  • you have asthma

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • under a doctor’s care for any serious condition
  • taking any other drug

When using this product

OTC - WHEN USING SECTION

  • take with food or milk if stomach upset occurs
  • the risk of heart attack or stroke may increase if you use more than directed or for longer than directed

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience any of the following signs of stomach bleeding:
  • feel faint
  • vomit blood
  • have bloody or black stools
  • have stomach pain that does not get better
  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • redness or swelling is present in the painful area
  • any new symptoms appear
  • you have difficulty swallowing
  • it feels like the capsule is stuck in your throat

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. It is especially important not to use naproxen sodium during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed
  • the smallest effective dose should be used
  • drink a full glass of water with each dose
  • if taken with food, this product may take longer to work

adults and children 12 years and older:

  • take 1 capsule every 8 to 12 hours while symptoms last
  • for the first dose you may take 2 capsules within the first hour
  • do not exceed 2 capsules in any 8- to 12-hour period
  • do not exceed 3 capsules in a 24-hour period

children under 12 years:

  • ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • each capsule contains: sodium 20 mg
  • store at 20-25°C (68-77°F) avoid high humidity and excessive heat above 40°C (104°F)
  • read all directions and warnings before use

Inactive ingredients

INACTIVE INGREDIENT SECTION

FD&C blue #1, gelatin, glycerin, lactic acid, mannitol, pharmaceutical ink, polyethylene glycol, povidone, propylene glycol, purified water, sorbitan, sorbitol

Questions or comments?

OTC - QUESTIONS SECTION

1-888-287-1915

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EASY OPEN CAP

Compare to the Active Ingredient of Aleve® Liquid Gels

Naproxen Sodium Capsules, 220 mg (NSAID)

Pain Reliever/Fever Reducer

THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN

Strength to Last 12 Hours

Actual Size

220 mg

80 LIQUID GELS**

**Liquid Filled Capsules

Equate Naproxen Sodium Image
Equate Naproxen Sodium Image

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1112231naproxen sodium 220 MG Oral CapsulePSN2
1112231naproxen sodium 220 MG Oral CapsuleSCD2
1112231naproxen sodium 220 MG (as naproxen 200 MG) Oral CapsuleSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
NAPROXEN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20191108

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49035-098-272020-01-31C16284748780-19d75b9d0-46c0-f424-e053-dadaa90a57ceWal-Mart Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49035-098-27Equate Naproxen Sodium80 in 1 BOTTLECAPSULE, LIQUID FILLED802

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49035-098EQUATE NAPROXEN SODIUM (NAPROXEN SODIUM) CAPSULE, LIQUID FILLED [WAL-MART STORES INC]2Legacy NDC, 1 package rows20140626_67ae566b-0d7f-45b8-8db2-683ca15e12d9.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3C2
NAPROXENACTIVE MOIETY57Y76R9ATQ2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBD2
GELATININACTIVE INGREDIENT2G86QN327L2
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
LACTIC ACIDINACTIVE INGREDIENT33X04XA5AT2
MANNITOLINACTIVE INGREDIENT3OWL53L36A2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A2
POVIDONESINACTIVE INGREDIENTFZ989GH94E2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
SORBITANINACTIVE INGREDIENT6O92ICV9RU2
SORBITOLINACTIVE INGREDIENT506T60A25R2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49035-09849035-098-27

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 397 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / RESPIRATORY (INHALATION)10 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATSOLUTION / TOPICAL7.22 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SWAB / TOPICAL34.6 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION, SOLUTION / SUBCUTANEOUS4.7 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER / ORAL36000 mgExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / VAGINAL750 mgExact identifier — unii candidate
81 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, FILM COATED, EXTENDED RELEASE / ORAL543 mgExact identifier — unii candidate
65 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
81 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPOWDER, FOR SUSPENSION / ORAL1 mg/5mlExact identifier — unii candidate
37 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RGUM, CHEWING / ORAL6168 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LINJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR2 mgExact identifier — unii candidate
44 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ECAPSULE / ORAL300 mgExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / OPHTHALMIC0.88 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LPOWDER / RESPIRATORY (INHALATION)100 mgExact identifier — unii candidate
44 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDLOTION / TOPICALNAExact identifier — unii candidate
37 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / TOPICAL4 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATSOLUTION / ORAL192 mgExact identifier — unii candidate
18 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXELIXIR / ORAL5621 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii candidate
81 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACAPSULE, DELAYED RELEASE / ORAL2043 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / SUBLINGUAL10.25 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACONCENTRATE / INTRAVENOUS220 mgExact identifier — unii candidate
65 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDFILM / SUBLINGUAL0.07 mgExact identifier — unii candidate
37 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / SUBCUTANEOUS4.54 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / TOPICAL1800 mgExact identifier — unii candidate
81 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE / ORAL10932 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION / SUBCUTANEOUS4.7 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATOINTMENT / TOPICALADJ PHExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / DENTAL20 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRAMUSCULAR450 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCONCENTRATE / ORAL1800 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LELIXIR / ORALNAExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RGUM, CHEWING / BUCCAL5110 mgExact identifier — unii candidate
44 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATINJECTION / INTRACARDIAC0.01 %w/vExact identifier — unii candidate
18 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR300 mgExact identifier — unii candidate
65 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RLOTION / TOPICAL10.7 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, EXTENDED RELEASE / ORAL265 mgExact identifier — unii candidate
75 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION / SUBCUTANEOUS675 mgExact identifier — unii candidate
65 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY, METERED / NASAL13 mgExact identifier — unii candidate
75 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDELIXIR / ORALNAExact identifier — unii candidate
37 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / ORAL45000 mgExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER, FOR SUSPENSION / ORAL12000 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LINJECTION / INTRAMUSCULAR16 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASUSPENSION/ DROPS / TOPICAL0.3 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, COATED / ORAL177.7 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, DELAYED RELEASE / ORAL639 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36APOWDER, FOR SUSPENSION / INTRAMUSCULAR6.75 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION / INTRA-ARTICULAR45 %w/vExact identifier — unii candidate
44 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021920-001NAPROXEN SODIUMNAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N021920-001100223442026-03-03U-1731Drug product2018-07-23
N021920-001100223442026-03-03U-1732Drug product2018-07-23
N021920-001100289252026-03-03U-1731Drug product2018-07-24
N021920-001100289252026-03-03U-1732Drug product2018-07-24
N021920-001110902802026-03-03U-1731Drug product2021-08-24
N021920-001110902802026-03-03U-1732Drug product2021-08-24
N021920-00196939782026-03-03Drug product2017-11-13
N021920-00196939792026-03-03Drug product2017-11-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1784e616aacf4f…
2026-08-18 06:07:402026-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1774a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1787673890dc5c…
2021-03-12 10:30 UTC2021-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-178869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173f01610625f2…
2019-09-15 20:21 UTC2019-09N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17b00525d2431f…
2019-07-19 19:46 UTC2019-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-176a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-171c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-179b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173f0d92c62455…
2023-05-13 08:27 UTC2023-05N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17053a50430f4f…
2023-01-26 05:58 UTC2023-01N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17f41ea6bd6efb…

Observed Orange Book patent history#

Patent history page 1 of 9 · 329 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N021920-001100223442026-03-03U-1731Drug product2018-07-2384e616aacf4f…
2026-09-14 22:38:342026-08N021920-001100223442026-03-03U-1732Drug product2018-07-2384e616aacf4f…
2026-09-14 22:38:342026-08N021920-001100289252026-03-03U-1731Drug product2018-07-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-001100289252026-03-03U-1732Drug product2018-07-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-001110902802026-03-03U-1731Drug product2021-08-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-001110902802026-03-03U-1732Drug product2021-08-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-00196939782026-03-03Drug product2017-11-1384e616aacf4f…
2026-09-14 22:38:342026-08N021920-00196939792026-03-03Drug product2017-11-1384e616aacf4f…
2026-08-18 06:07:402026-07N021920-001100223442026-03-03U-1731Drug product2018-07-23caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001100223442026-03-03U-1732Drug product2018-07-23caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001100289252026-03-03U-1731Drug product2018-07-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001100289252026-03-03U-1732Drug product2018-07-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001110902802026-03-03U-1731Drug product2021-08-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001110902802026-03-03U-1732Drug product2021-08-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-00196939782026-03-03Drug product2017-11-13caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-00196939792026-03-03Drug product2017-11-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021920-001100223442026-03-03U-1731Drug product2018-07-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001100223442026-03-03U-1732Drug product2018-07-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001100289252026-03-03U-1731Drug product2018-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001100289252026-03-03U-1732Drug product2018-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001110902802026-03-03U-1731Drug product2021-08-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001110902802026-03-03U-1732Drug product2021-08-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-00196939782026-03-03Drug product2017-11-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-00196939792026-03-03Drug product2017-11-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100223442026-03-03U-1731Drug product2018-07-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100223442026-03-03U-1732Drug product2018-07-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100289252026-03-03U-1731Drug product2018-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100289252026-03-03U-1732Drug product2018-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001110902802026-03-03U-1731Drug product2021-08-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001110902802026-03-03U-1732Drug product2021-08-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-00196939782026-03-03Drug product2017-11-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-00196939792026-03-03Drug product2017-11-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08N021920-001100223442026-03-03U-1731Drug product2018-07-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001100223442026-03-03U-1732Drug product2018-07-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001100289252026-03-03U-1731Drug product2018-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001100289252026-03-03U-1732Drug product2018-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001110902802026-03-03U-1731Drug product2021-08-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001110902802026-03-03U-1732Drug product2021-08-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-00196939782026-03-03Drug product2017-11-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-00196939792026-03-03Drug product2017-11-136a471c1ec25d…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e24b94b8-96d9-4297-be24-12a7f6bb17b667ae566b-0d7f-45b8-8db2-683ca15e12d92014-06-25WarningsExact identifier
spl id: e24b94b8-96d9-4297-be24-12a7f6bb17b6
spl set id: 67ae566b-0d7f-45b8-8db2-683ca15e12d9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.